Works matching IS 14655411 AND DT 2014 AND VI 16 AND IP 4


Results: 50
    1
    2
    3
    4
    5
    6

    Risk determination and prevention of breast cancer.

    Published in:
    2014
    By:
    • Howell, Anthony;
    • Anderson, Annie S;
    • Clarke, Robert B;
    • Duffy, Stephen W;
    • Evans, D Gareth;
    • Garcia-Closas, Montserat;
    • Gescher, Andy J;
    • Key, Timothy J;
    • Saxton, John M;
    • Harvie, Michelle N
    Publication type:
    journal article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    19
    20
    21
    22
    23
    24
    25
    26

    Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.

    Published in:
    2014
    By:
    • Fu, Xiaoyong;
    • Creighton, Chad J;
    • Biswal, Nrusingh C;
    • Kumar, Vijetha;
    • Shea, Martin;
    • Herrera, Sabrina;
    • Contreras, Alejandro;
    • Gutierrez, Carolina;
    • Wang, Tao;
    • Nanda, Sarmistha;
    • Giuliano, Mario;
    • Morrison, Gladys;
    • Nardone, Agostina;
    • Karlin, Kristen L;
    • Westbrook, Thomas F;
    • Heiser, Laura M;
    • Anur, Pavana;
    • Spellman, Paul;
    • Guichard, Sylvie M;
    • Smith, Paul D
    Publication type:
    journal article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    The dynamic range of circulating tumor DNA in metastatic breast cancer.

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 4, p. 2, doi. 10.1186/s13058-014-0421-y
    By:
    • Heidary, Maryam;
    • Auer, Martina;
    • Ulz, Peter;
    • Heitzer, Ellen;
    • Petru, Edgar;
    • Gasch, Christin;
    • Riethdorf, Sabine;
    • Mauermann, Oliver;
    • Lafer, Ingrid;
    • Pristauz, Gunda;
    • Lax, Sigurd;
    • Pantel, Klaus;
    • Geigl, Jochen B.;
    • Speicher, Michael R.
    Publication type:
    Article
    39
    40
    41

    PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 4, p. 2, doi. 10.1186/s13058-014-0406-x
    By:
    • Lehmann, Brian D.;
    • Bauer, Joshua A.;
    • Schafer, Johanna M.;
    • Pendleton, Christopher S.;
    • Luojia Tang;
    • Johnson, Kimberly C.;
    • Xi Chen;
    • Balko, Justin M.;
    • Gòmez, Henry;
    • Arteaga, Carlos L.;
    • Mills, Gordon B.;
    • Sanders, Melinda E.;
    • Pietenpol, Jennifer A.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2 positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 4, p. 1, doi. 10.1186/s13058-014-0405-y
    By:
    • Binghe Xu;
    • Zhongzhen Guan;
    • Zhenzhou Shen;
    • Zhongshen Tong;
    • Zefei Jiang;
    • Junlan Yang;
    • DeSilvio, Michelle;
    • Russo, Mark;
    • Leigh, Meggan;
    • Ellis, Catherine
    Publication type:
    Article
    50